Colinz Laboratories Limited (BOM:531210)
72.56
+1.06 (1.48%)
At close: Sep 4, 2026
Colinz Laboratories Revenue
Colinz Laboratories had revenue of 12.41M INR in the quarter ending June 30, 2026, a decrease of -20.76%. This brings the company's revenue in the last twelve months to 58.11M, down -8.45% year-over-year. In the fiscal year ending March 31, 2026, Colinz Laboratories had annual revenue of 61.36M, down -6.00%.
Revenue (ttm)
58.11M
Revenue Growth
-8.45%
P/S Ratio
3.15
Revenue / Employee
937.24K
Employees
62
Market Cap
182.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 61.36M | -3.92M | -6.00% |
| Mar 31, 2025 | 65.28M | -5.02M | -7.14% |
| Mar 31, 2024 | 70.30M | -1.25M | -1.75% |
| Mar 31, 2023 | 71.55M | 1.81M | 2.59% |
| Mar 31, 2022 | 69.74M | 8.15M | 13.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.71B |
| Walpar Nutritions | 757.46M |
| Beryl Drugs | 213.23M |
| Unjha Formulations | 152.79M |
| Zenith Healthcare | 108.46M |
| Hamps Bio | 84.75M |
| Norris Medicines | 76.00M |
| Desh Rakshak Aushdhalaya | 66.33M |